Carclo (Carclo) Cash And Cash Equivalents : $8.9 Mil (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Carclo Cash And Cash Equivalents?

Carclo's quarterly cash and cash equivalents increased from Sep. 2022 ($12.15 Mil) to Mar. 2023 ($12.57 Mil) but then stayed the same from Mar. 2023 ($12.57 Mil) to Sep. 2023 ($8.89 Mil).

Carclo's annual cash and cash equivalents declined from Mar. 2021 ($21.48 Mil) to Mar. 2022 ($16.27 Mil) and declined from Mar. 2022 ($16.27 Mil) to Mar. 2023 ($12.57 Mil).

Carclo Cash And Cash Equivalents Historical Data

The historical data trend for Carclo's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carclo Cash And Cash Equivalents Chart

Carclo Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash And Cash Equivalents

Get a 7-Day Free Trial

13.61

23.90

21.48

16.27

12.57

Carclo Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Cash And Cash Equivalents	Get a 7-Day Free Trial															14.28	16.27	12.15	12.57	8.89

Carclo Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Carclo (OTCPK:CCEGF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Carclo Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Carclo's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Carclo (Carclo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Vehicles & Parts » Carclo PLC (OTCPK:CCEGF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

CARl:UK CAR.GB:UK CAR:UK C1Y:Germany

Address

Unit 5, Silkwood Court, Ossett, W Yorks, GBR, WF5 9TP

Website

http://www.carclo-plc.com

Carclo PLC is a technology-led plastics group that is engaged in three segments: CTP, Aerospace, and Central. The CTP segment supplies value-adding engineered solutions for the life science, optical and precision component industries. This business operates internationally in a fast?growing and dynamic market underpinned by rapid technological development. The Aerospace segment supplies systems to the manufacturing and aerospace industries. The central segment relates to central costs and non-trading companies. Geographically, it operates in the regions of the UK, North America, China, and India. The company earns three-fifths of its revenue from medical products, and the balance of the revenue is generated from the automotive industry.